Editorial

Sallmann L (1950) Experimental study on the vitreous; II. Experiments on disappearance of red blood cells from the vitreous effects of hyaluronidase; effect of short bouts of artificial fever and changes in the basic metabolic rate. Arch Ophthalmol 43(4): 638–52

Henry K et al (1987) Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol 103(1): 17–23

Blankenship GW (1989) Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases. Graefes Arch Clin Exp Ophthalmol 227(6): 565–8

Hassan AS et al (1999) Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 106(10): 1900–6; discussion 1906–7

Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132(3): 425–7

Benhamou N et al (2003) Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135(2): 246–9

Bynoe LA, Weiss JN (2003) Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol 135(3): 382–4

Antcliff RJ et al (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108(4): 765–72

Penfold PL et al (1995) Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust N Z J Ophthalmol 23(4): 293–8

Krepier K, Wagner J, Sacu S, Wedrich A (2004) The effect of intravitreal triamcinolone on diabetic macular edema. Graefes Arch Clin Exp Ophthalmol, Epub

Isenberg SJ et al (1985) Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol 103(9): 1340–2

Mather R et al (2002) Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133(4): 463–6

Moshfeghi DM et al (2003) Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136(5): 791–6

Kupperman BD et al (2004) Ovine hyaluronidase (Vitrase, an investigational drug) reduces vitreous hemorrhage density (RVHD) and improves est corrected visual acuity (BCVA): Integrated results from 2 phase III studies. Presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology, April 25–29; Ft. Lauderdale, Florida

Danis RP et al (2000) Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20(3): 244–50

Gragoudas ES et al (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351(27): 2805–16

Jager RD et al (2004) Risks of intravitreous injection: a comprehensive review. Retina 24(5): 676–98

Eifrig CW et al (2002) Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995–2001). Ophthalmic Surg Lasers 33(5): 373–8

Sandvig KU, Dannevig L (2003) Postoperative endophthalmitis: establishment and results of a national registry. J Cataract Refract Surg 29(7): 1273–80

Nelson ML et al (2003) Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23(5): 686–91

Endophthalmitis Vitrectomy Study Group (1995) Results of the endophthalmitis vitrectomy study group. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113: 1479–1496

Sutter FKP, Gillies MC (2003) Interim (3 months) analysis of the safety of intravitreal triamcinolone for diabetic macular edema that persists after laser treatment. Results from a randomized clinical trial: TDMO. Invest Ophthalmol Vis Sci 44: 454

Benz MS et al (2003) Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 121(2): 271–3

Müller M et al (2003) Komplikationen nach intravitrealer Triamcinolon-Acetonid-Injektion. Ophthalmologe 100: 192, Abstract.

Nelson ML, Martidis A (2003) Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 14(1): 39–43

Modarres M, Parvaresh MM, Peyman GA (1998) Accidental subretinal injection of triamcinolone acetonide. Ophthalmic Surg Lasers 29(11): 935–8

Bakri SJ, Beer PM (2003) The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging 34(5): 386–90

Wingate RJ, Beaumont PE (1999) Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 27(6): 431–2

Gillies MC et al (2005) Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology 112(1): 139–43

Food and Drug Administration Department of Health & Human Services (2004) New drug application (NDA) 21–756. Macugen (pegaptanib sodium injection) application information